Terumo Corporation (TRUMF)
| Previous close | 17.40 |
| Open | 16.63 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 16.63 - 16.63 |
| 52-week range | 12.48 - 19.84 |
| Volume | |
| Avg. volume | 1,883 |
| Market cap | 24.689B |
| Beta (5Y monthly) | 0.50 |
| PE ratio (TTM) | 39.59 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.15 (0.84%) |
| Ex-dividend date | 28 Mar 2024 |
| 1y target est | N/A |
- PR Newswire
Terumo Medical Corporation's New AZUR HydroPack™ Peripheral Coil System Provides a Soft-Packing, Long-Lasting Solution to Embolotherapy
Terumo Medical Corporation is pleased to announce the launch of its new AZUR HydroPack Peripheral Coil System in the United States. The AZUR HydroPack Coil System is a soft, universal-shaped platinum and hydrogel coil designed to find and fill empty space within the vessel. It is also the only packing coil to use proprietary designed hydrogel technology to create a gel core for mechanical occlusion, a unique feature of AZUR peripheral coils.[1] Terumo received Food and Drug Administration cleara
- Business Wire
MicroVention Celebrates 10-Year Anniversary and Legacy of SOFIA™ Aspiration Catheters; More than 500,000 Procedures Performed Worldwide Across 170 Countries
MIAMI & ALISO VIEJO, Calif., November 16, 2023--MicroVention Celebrates 10-Year Anniversary and Legacy of SOFIA™ Aspiration Catheters
- Business Wire
MicroVention Enters Transradial Access Therapy; Receives FDA Clearance of SOFIA™ EX 5F 115cm Intracranial Support Catheter
ALISO VIEJO, Calif., September 21, 2023--MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced that the SOFIA™ EX 5F 115 cm Intracranial Support Catheter (Soft TOrqueable catheter For Intracranial Access) has received FDA 510(k) clearance on September 15, 2023, for transradial access in addition to transfemoral access. The unique design of the SOFIA™ EX 5F Catheter allows for great trackability and a large inside lumen provides a fa
